Maximize Your Returns with AI-Powered FHI Insights

---

Trade smarter with daily optimized FHI trades + news analysis

Rushing Into Growth Strategy Comes At A Cost

politics

ZeroHedge Opinion     Nov 24, 2023

Insider Sell Alert: EVP, CLO & Sec. Peter Germain Sells 5,254 Shares of Federated Hermes ... - Yahoo Finance

In the realm of stock market movements, insider trading activity is often a significant indicator that investors keep a close eye on. Recently, an insider sell event has caught the attention of the market. Peter Germain, the Executive Vice President, Chief Legal Officer, and Secretary of Federated Hermes Inc (NYSE:FHI), has sold 5,254 shares of the company on November 20, 2023. This transaction has prompted a closer look into the insider's trading behavior, the company's business operations, and the potential implications for the stock's valuation.Who is Peter Germain?Peter Germain is a seasoned executive at Federated Hermes Inc, holding the positions of Executive Vice President, Chief Legal Officer, and Secretary.

Yahoo     Nov 22, 2023

La-Z-Boy Incorporated (NYSE:LZB) Shares Sold by Texas ... - Defense World

Texas Permanent School Fund Corp lowered its stake in shares of La-Z-Boy Incorporated (NYSE:LZB – Free Report) by 1.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 37,984 shares of the company’s stock after selling 700 shares during the quarter. Texas Permanent School Fund Corp owned approximately 0.09% of La-Z-Boy worth $1,088,000 at the end of the most recent reporting period.

defenseworld.net     Nov 20, 2023

Should You Invest In IPOs? It's Still A Risky Prospect - Kiplinger's Personal Finance

Should You Invest In IPOs? It's Still A Risky ProspectKiplinger's Personal Finance

kiplinger.com     Nov 23, 2023

Ready to Jump After Recent Trade: Seres Therapeutics Inc (MCRB) - SETE News

Seres Therapeutics Inc (NASDAQ: MCRB) stock fell -31.68% on Monday to $0.97 against a previous-day closing price of $1.42. With 13.4 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.19 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.4150 whereas the lowest price it dropped to was $0.9656. The 52-week range on MCRB shows that it touched its highest point at $7.30 and its lowest point at $0.91 during that stretch. It currently has a 1-year price target of $9.25. Beta for the stock currently stands at 2.63.

setenews.com     Nov 21, 2023